Clinical trials
Phase 1/2 Lung Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2009 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 6 |
| Terminated | 4 |
| Withdrawn | 3 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Unknown status | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 2 |
| Revolution Medicines, Inc. | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Adverum Biotechnologies, Inc. | 1 |
| Aeris Therapeutics | 1 |
| Baylor College of Medicine | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Celularity Incorporated | 1 |
| Chan, Stephen, MD, PhD | 1 |
| Grifols Therapeutics LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 29 |
| Respiratory Tract Diseases | 12 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Lung Neoplasms | 10 |
| Neoplasms | 9 |
| Thoracic Neoplasms | 9 |
| Bronchial Neoplasms | 7 |
| Neoplasms by Site | 7 |
| Respiratory Tract Neoplasms | 7 |
| Pulmonary Disease, Chronic Obstructive | 6 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.